Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-06-26 @ 4:54 AM
Study NCT ID:
NCT03594058
Status:
COMPLETED
Last Update Posted:
2020-03-02
First Post:
2018-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001)
Sponsor:
Velicept Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Overactive Bladder | View |